Regeneron Pharmaceuticals（纳斯达克代码：REGN）报告第四季度调整后每股收益为 $12.07，较分析师一致预期的 $11.29 高出 6.91%，与去年同期的 $11.86 相比增长了 1.77%。公司本季度销售额为 $37.90 亿，超过分析师一致预期的 $37.51 亿，高出 1.04%，较去年同期的 $34.34 亿增长了 10.37%。

以上内容来自Benzinga Earnings专栏，原文如下：

Regeneron Pharmaceuticals (NASDAQ:REGN) reported quarterly earnings of $12.07 per share which beat the analyst consensus estimate of $11.29 by 6.91 percent. This is a 1.77 percent increase over earnings of $11.86 per share from the same period last year. The company reported quarterly sales of $3.790 billion which beat the analyst consensus estimate of $3.751 billion by 1.04 percent. This is a 10.37 percent increase over sales of $3.434 billion the same period last year.